日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection.

一种预测肝细胞癌患者R0切除术后早期复发的新型列线图

Wang Huanhuan, Liu Runkun, Mo Huanye, Li Runtian, Lian Jie, Liu Qingguang, Han Shaoshan

Correction to: Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression

更正:基质硬度通过E2F3依赖性信号通路调节肝星状细胞活化为促肿瘤肌成纤维细胞,并调控恶性进展。

Liu, Zhikui; Mo, Huanye; Liu, Runkun; Niu, Yongshen; Chen, Tianxiang; Xu, Qiuran; Tu, Kangsheng; Yang, Nan

Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression

长链非编码RNA MAPKAPK5-AS1/PLAGL2/HIF-1α信号环路促进肝细胞癌进展

Wang, Liang; Sun, Liankang; Liu, Runkun; Mo, Huanye; Niu, Yongshen; Chen, Tianxiang; Wang, Yufeng; Han, Shaoshan; Tu, Kangsheng; Liu, Qingguang

A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma

一种新型乳酸代谢相关基因特征可用于预测肝细胞癌的临床结果和肿瘤微环境

Li, Yue; Mo, Huanye; Wu, Shengli; Liu, Xin; Tu, Kangsheng

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma

肝细胞癌氧化还原免疫预后特征的鉴定与验证

Tu, Kangsheng; Li, Jin; Mo, Huanye; Xian, Yao; Xu, Qiuran; Xiao, Xuelian

Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway

长链非编码RNA PICSAR/miR-588/EIF6轴通过激活PI3K/AKT/mTOR信号通路调控肝细胞癌的发生发展

Liu, Zhikui; Mo, Huanye; Sun, Liankang; Wang, Liang; Chen, Tianxiang; Yao, Bowen; Liu, Runkun; Niu, Yongshen; Tu, Kangsheng; Xu, Qiuran; Yang, Nan

NIRF-Molecular Imaging with Synovial Macrophages-Targeting Vsig4 Nanobody for Disease Monitoring in a Mouse Model of Arthritis

利用滑膜巨噬细胞靶向Vsig4纳米抗体进行近红外荧光分子成像,用于小鼠关节炎模型疾病监测

Zheng, Fang; Luo, Siyu; Ouyang, Zhenlin; Zhou, Jinhong; Mo, Huanye; Schoonooghe, Steve; Muyldermans, Serge; De Baetselier, Patrick; Raes, Geert; Wen, Yurong